Gala dinner of the synuclein meeting at King’s college, Cambridge, UK. What a setting! ❤️
Posts by Constantin
Virginia Lee, PhD in stage at the 2025 #synuclein meeting, Cambridge, UK. She doesn’t need an introduction. 80 years old and still going strong as a key opinion leader in neurodegenerative disorders like Alzheimer’s and Parkinson’s disease. #parkinson #synuclein #drugdiscovery #neuroscience
Great presentations, posters and discussions at the 2025 synuclein meeting in Cambridge, UK! #synuclein #parkinsonsdisease #drugdiscovery
A letter from the Editors of the international scientific journal Nature to President-Elect Mr. Trump. Worth a read !
🧠 The Race to Treat Alzheimer’s: Are We on the Right Path?
Pharma focused on amyloid- and tau-targeting therapies, with recent approvals marking a turning point. Yet, these therapies face questions about efficacy, costs, etc.
But are amyloid and tau the endgame, or should we broaden our horizons?
🗨️ Let’s Talk:
What breakthroughs in neuroscience or biotech excite you the most right now? Let’s start a conversation!
Here’s to building something meaningful together. 🚀
#Neuroscience #Biotech #Entrepreneurship #DrugDiscovery #ArtAndScience
🤝 Why I’m Here:
I’m here to connect, learn, and share ideas about neuroscience, drug discovery, entrepreneurship, and even the intersections of art and science. I believe great conversations spark innovation!
#Neuroscience #Biotech #Pharmacology #Entrepreneurship #DrugDiscovery
🎯 My Mission:
One day, I hope to launch my own biotech company focused on developing therapies for neurodegenerative diseases like Alzheimer's, Parkinson's, and neuromuscular disorders. These conditions affect millions of lives, and I’m determined to make a difference.
#Neuroscience #DrugDiscovery
🌟 Hello Bluesky! 🌟
🧠 Who I Am:
I’m a neuroscientist with a passion for understanding the brain, a drug hunter dedicated to discovering therapies, a leader who gets energized when building high performing teams.
#Neuroscience #Biotech #Pharma #DrugDiscovery